RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rohto Pharmaceutical Co Stock

Rohto Pharmaceutical Co ROA 2024

Rohto Pharmaceutical Co ROA

0.09

Ticker

4527.T

ISIN

JP3982400008

WKN

858075

In 2024, Rohto Pharmaceutical Co's return on assets (ROA) was 0.09, a 16.27% increase from the 0.08 ROA in the previous year.

Rohto Pharmaceutical Co Aktienanalyse

What does Rohto Pharmaceutical Co do?

Rohto Pharmaceutical Co Ltd is a leading Japanese company in the pharmaceutical and cosmetic products industry, founded in 1899. The company was originally established as a small company to manufacture herbal medicine before undergoing several mergers and acquisitions to become the company we know today. Rohto Pharmaceutical's business model focuses on developing and marketing innovative products for health and beauty. The company has a global reputation for its high-quality products that undergo stringent testing to ensure they are safe and effective. Rohto Pharmaceutical has various business divisions. One of the main areas is the pharmaceutical division, which manufactures medications for various ailments, including ophthalmology, pain relief, and skincare. Another important business area is Rohto Pharmaceutical's cosmetics division, which offers a wide range of facial care products, sunscreen, and whitening products. The company is known for its lotions and emulsions that are based on high-quality ingredients such as vitamin C, hyaluronic acid, and collagen. Over the years, Rohto Pharmaceutical has also launched several groundbreaking products. For example, the company developed the world's first eye drop product for dry eyes. Another groundbreaking invention by Rohto is the invention of menthol cooling effects in eye drops, which are intended to provide a refreshing sensation in the eyes. Rohto Pharmaceutical has developed innovative technologies and production facilities with cleanroom laboratories for pharmaceutical and cosmetic products. The company's technological advancements also include the development of hybrid companies that combine the competencies of pharmacists and cosmetologists, facilitating the development of products for the beauty and health sectors. Although Rohto Pharmaceutical has focused its efforts on the Japanese market, the company has also opened branches in other countries, including the USA, Europe, and Asia. As a result, Rohto offers a wide range of products such as menthol spray, sunscreen, and eye drops that are sold worldwide. Conclusion: Rohto Pharmaceutical is a leading provider of pharmaceutical and cosmetic products. The company has built its reputation based on its innovative products, stringent quality controls, and groundbreaking technologies. Rohto Pharmaceutical has a vision that encompasses "building health, creating beauty, and making life easier." By dividing its business into various divisions, the company is able to offer a wide range of health and beauty products to meet customer needs. Rohto Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Rohto Pharmaceutical Co's Return on Assets (ROA)

Rohto Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Rohto Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Rohto Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Rohto Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Rohto Pharmaceutical Co stock

What is the Return on Assets (ROA) of Rohto Pharmaceutical Co this year?

The Return on Assets (ROA) of Rohto Pharmaceutical Co is 0.09 undefined this year.

What was the ROA of Rohto Pharmaceutical Co compared to the previous year?

The ROA of Rohto Pharmaceutical Co has increased by 16.27% compared to the previous year.

What consequences do high ROA have for investors of Rohto Pharmaceutical Co?

A high ROA is advantageous for investors of Rohto Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Rohto Pharmaceutical Co?

A low ROA can be unfavorable for investors of Rohto Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Rohto Pharmaceutical Co affect the company?

An increase in ROA of Rohto Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Rohto Pharmaceutical Co impact the company?

A reduction in the ROA of Rohto Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Rohto Pharmaceutical Co?

Some factors that can influence the ROA of Rohto Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Rohto Pharmaceutical Co important for investors?

The ROA of Rohto Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Rohto Pharmaceutical Co take to improve ROA?

To improve ROA, Rohto Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Rohto Pharmaceutical Co pay?

Over the past 12 months, Rohto Pharmaceutical Co paid a dividend of 31 JPY . This corresponds to a dividend yield of about 0.87 %. For the coming 12 months, Rohto Pharmaceutical Co is expected to pay a dividend of 33.11 JPY.

What is the dividend yield of Rohto Pharmaceutical Co?

The current dividend yield of Rohto Pharmaceutical Co is 0.87 %.

When does Rohto Pharmaceutical Co pay dividends?

Rohto Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Rohto Pharmaceutical Co?

Rohto Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Rohto Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 33.11 JPY are expected. This corresponds to a dividend yield of 0.93 %.

In which sector is Rohto Pharmaceutical Co located?

Rohto Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Rohto Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rohto Pharmaceutical Co from 12/1/2024 amounting to 16 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Rohto Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Rohto Pharmaceutical Co in the year 2023?

In the year 2023, Rohto Pharmaceutical Co distributed 24 JPY as dividends.

In which currency does Rohto Pharmaceutical Co pay out the dividend?

The dividends of Rohto Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rohto Pharmaceutical Co

Our stock analysis for Rohto Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rohto Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.